DK2037949T3 - Fremgangsmåde til at fremstille et "transfer-faktor" medikament - Google Patents

Fremgangsmåde til at fremstille et "transfer-faktor" medikament

Info

Publication number
DK2037949T3
DK2037949T3 DK07721839.4T DK07721839T DK2037949T3 DK 2037949 T3 DK2037949 T3 DK 2037949T3 DK 07721839 T DK07721839 T DK 07721839T DK 2037949 T3 DK2037949 T3 DK 2037949T3
Authority
DK
Denmark
Prior art keywords
medicament
transfer factor
manufacturing
lyophylisation
normalisation
Prior art date
Application number
DK07721839.4T
Other languages
English (en)
Inventor
Jan Pekarek
Original Assignee
Sevapharma A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sevapharma A S filed Critical Sevapharma A S
Application granted granted Critical
Publication of DK2037949T3 publication Critical patent/DK2037949T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK07721839.4T 2006-06-13 2007-06-12 Fremgangsmåde til at fremstille et "transfer-faktor" medikament DK2037949T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060377A CZ299296B6 (cs) 2006-06-13 2006-06-13 Lécivo transfer faktor - zpusob výroby a použití
PCT/CZ2007/000050 WO2007143957A2 (en) 2006-06-13 2007-06-12 'transfer factor' medicament - ways of manufacturing and use

Publications (1)

Publication Number Publication Date
DK2037949T3 true DK2037949T3 (da) 2012-06-18

Family

ID=38220655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07721839.4T DK2037949T3 (da) 2006-06-13 2007-06-12 Fremgangsmåde til at fremstille et "transfer-faktor" medikament

Country Status (9)

Country Link
EP (1) EP2037949B1 (da)
AT (1) ATE547111T1 (da)
CY (1) CY1113372T1 (da)
CZ (1) CZ299296B6 (da)
DK (1) DK2037949T3 (da)
ES (1) ES2383351T3 (da)
PL (1) PL2037949T3 (da)
SI (1) SI2037949T1 (da)
WO (1) WO2007143957A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX338863B (es) 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.
CZ2020342A3 (cs) * 2020-06-12 2021-12-22 AUMED, a.s. Způsob přípravy léčiva transfer faktor, léčivo transfer faktor, metodika testování biologické účinnosti, léková forma a její použití
CN113304172A (zh) * 2021-06-10 2021-08-27 哈尔滨圣泰生物制药有限公司 一种转移因子口服溶液的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
JPS56500015A (da) * 1978-10-25 1981-01-08
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
AU1696283A (en) * 1982-07-20 1984-01-26 Bio-Com Inc. Transfer factor for viral treatment
DE3244607A1 (de) * 1982-12-02 1984-06-07 Bezirksblutspendezentrale Plauen, DDR 9900 Plauen Verfahren zur herstellung von humanen transfer-faktor-praeparaten
DK0537280T3 (da) * 1990-07-02 1997-10-13 Nat Jewish Ct Immun & Respirat Fremstilling og anvendelse af transfer-faktor
CN1093907A (zh) * 1993-12-19 1994-10-26 陕西省生物制品研究所 口服转移因子
MXPA02002171A (es) * 2002-02-28 2002-12-09 Antonio Calzada Nova Luis Extracto de leucocitos dializado en la elaboracion de un farmaco para el tratamiento de enfermedades infecciosas en animales.
CN100413534C (zh) * 2003-11-03 2008-08-27 西北农林科技大学 一种治疗奶牛临床乳房炎的生物性免疫制剂及其制作方法
CN1654477A (zh) * 2004-02-13 2005-08-17 北京世纪昭宝转移因子研究中心 制备转移因子工艺方法－加热法

Also Published As

Publication number Publication date
CY1113372T1 (el) 2016-06-22
EP2037949B1 (en) 2012-02-29
ES2383351T3 (es) 2012-06-20
SI2037949T1 (sl) 2012-07-31
WO2007143957B1 (en) 2008-06-26
PL2037949T3 (pl) 2012-10-31
WO2007143957A2 (en) 2007-12-21
CZ299296B6 (cs) 2008-06-11
EP2037949A2 (en) 2009-03-25
WO2007143957A3 (en) 2008-05-08
CZ2006377A3 (cs) 2007-07-04
ATE547111T1 (de) 2012-03-15

Similar Documents

Publication Publication Date Title
WO2007118235A3 (en) Filtration system for preparation of fluids for medical applications.
MX2015012556A (es) Sistema y metodo para intercambio de dialisis peritoneal teniendo una unidad energizante reutilizable.
BRPI0821027B8 (pt) 4-(4-ciano-2-tioaril)di-hidropirimidinonas para tratamento e/ou prevenção de lesões do pulmão e do sistema cardiovascular, seu processo de preparação e seu uso, e medicamento
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
NZ612105A (en) Human milk oligosaccharides for modulating inflammation
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
MY159377A (en) Aqueous suspensions of ciclesonide for nebulisation
GB201303983D0 (en) Drug and method for the prophylaxis of HIV infection and for the prophylaxis and treatment of diseases caused by or associated with HIV, including AIDS
EP1728076A4 (en) SYSTEM AND METHOD FOR PROVIDING OPTIMUM CONCENTRATIONS FOR MEDICAMENT INFUSIONS
PL2037949T3 (pl) Sposób wytwarzania preparatu o nazwie czynnik przekazu
CN204484535U (zh) 一种疾病预防控制床
BR0112131A (pt) Composições farmacêuticas e métodos para uso
SE0301577L (sv) Lösning med låg natriumhalt
ATE482705T1 (de) Antibakterielle behandlung von osteoarthritis
BR112014005221A2 (pt) uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes
CN201692228U (zh) 一种护士用臂套
Maraki et al. Peritonitis due to Streptococcus gordonii in a patient treated with continuous ambulatory peritoneal dialysis
Kalivas et al. Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders
Kloos Crisantaspase/pegaspargase
FENG et al. The efficacy study of chitosan in combination with far infrared treatment on the blood flow of arteriovenous fistula
Glatstein Atropa belladonna
Yuhico Development of multi-drug resistant Pseudomonas aeruginosa: case report
Erol Zoledronic acid
UA84047U (ru) Способ лечения вторичных нарушений системы гемостаза у больных гемофилией с большими интрамышечными гематомами